The compatibility between biocontrol agents and pesticides seems to be a sustainable control strategy in agriculture. Therefore, the in vitro compatibility of three native isolates of Trichoderma was evaluated in three concentrations of chlorpyrifos (960, 1200, and 1440 mg/L), by determining the effect on spore germination, mycelial growth, and the antagonistic capacity. The isolates correspond to Trichoderma asperellum TCA 3, Trichoderma asperellum TCA 21 and Trichoderma harzianum TCA 23. Both spore germination and mycelial growth were performed using the poisoned medium method, while the antagonistic capacity was evaluated against Botrytis sp. in a dual culture. The results showed that TCA 21 strain had a higher germination percentage (79.46, 59.79, and 37.43%) than the TCA 3 and TCA 23 strains, in the three concentrations of chlorpyrifos. Regarding the mycelial growth of the three native strains in chlorpyrifos are affected when concentration of chlorpyrifos increase (p < 0.05). Finally, the antagonistic capacity of the three strains was not affected by any concentration of chlorpyrifos, where strains TCA 21 and TCA 23 presented a degree of antagonism of one, while TCA 3 presented a degree of two, according to the scale used by Bell. In conclusion, T. asperellum TCA 21 was the one that presented the best in vitro compatibility with chlorpyrifos at concentrations of 960 and 1200 mg/L, compared to T. asperellum TCA 3 and TCA 23. These results are favorable for field application since these native strains can also have the ability to degrade the insecticide, representing a sustainable and eco-friendly alternative to the environment.

This scientometric and bibliometric study analyzes global research trends on polyhydroxyalkanoate (PHA)-producing microorganisms and their applications in bio-based packaging between 2014 and 2025. Using the Scopus database and advanced tools such as Bibliometrix in RStudio and VOSviewer, scientific output and international collaboration networks were evaluated. The results demonstrate exponential growth in publications, driven by the urgent need to mitigate the petrochemical plastics crisis and develop biodegradable alternatives within the circular economy. Multidisciplinary analysis reveals a thematic shift from basic physiological and taxonomic studies towards complex applications in metabolic engineering, synthetic biology, the optimization of low-cost substrates such as industrial effluents, multi-omics tools, gene editing with CRISPR-Cas9, and, as an emerging exploratory approach, quantum modeling to optimize cell performance. Despite significant progress, critical technological gaps were identified related to challenges in downstream processing, the management of mixed microbial communities, and insufficient funding for the characterization of physicochemical and biocompatibility properties. It is concluded that, to ensure the commercial scalability and sustainability of PHAs, future research must prioritize overcoming these economic and technological bottlenecks, fostering strategic collaboration between academia and the biotechnology industry.